Levothyroxine Sodium Tablet
Product Images NDC 51655-739

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 739 52 Master Bottle Label Approval Rev A 06 21)

Label (51655 739 52 Master Bottle Label Approval Rev A 06 21)
Levothyroxine Sodium is a medication available in the form of 30 Tablets with each containing 50 mcg (0.05mg) of the active ingredient. It is essential to store this medication in a dry place and protect it from light. The drug should be kept out of children’s reach and stored in the original container at a controlled room temperature of 25°C (77°F) with excursions permitted to 75°-30°C (59°-86°F). This medication is Rx only, and its dosage instructions are available in the package insert. The drug is repackaged by Northwind Pharmaceuticals and manufactured by Accord Healthcare. The details about the medication’s components, batch number, and expiry date are also mentioned.*
FDA Label Image

Description (Levothyroxine Str)

Description (Levothyroxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.